A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.
About This Bill
Committee
Latest Action · March 19, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.